USD 16.32
(-2.86%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | 29.07 Million | -35.73 Million |
Net Income | 97.86 Million | -106.29 Million | 99.35 Million | 62.9 Million | 29.07 Million | -35.73 Million |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | 46.56 Thousand | 151.64 Thousand |
Other non-cash items | -97.86 Million | 106.29 Million | -99.35 Million | -62.9 Million | -29.07 Million | 35.73 Million |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | -63.16 Million | -147.79 Million |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | -476.87 Thousand | -25.43 Million |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | 46.56 Thousand | 151.64 Thousand |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | -46.56 Thousand | -151.64 Thousand |
Cash at beginning of period | - | 6.05 Million | 2.2 Million | 1.67 Million | 15.4 Million | 13.47 Million |
Cash at end of period | - | 7.41 Million | 6.05 Million | 2.2 Million | 1.67 Million | 15.4 Million |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | 1.36 Million | 3.85 Million | 523.51 Thousand | -13.72 Million | 1.93 Million |
Free Cash Flow | - | - | - | - | 29.07 Million | -35.73 Million |
Breakdown | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 | 2022 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 97.86 Million | 59.89 Million | 37.96 Million | -106.29 Million | 18.43 Million | -124.72 Million |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | -97.86 Million | -59.89 Million | -37.96 Million | 106.29 Million | -18.43 Million | 124.72 Million |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | - | - | 7.41 Million | 6.05 Million | 1.97 Million | 6.05 Million |
Cash at end of period | - | - | 793 Thousand | 7.41 Million | 7.41 Million | 1.97 Million |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | -6.62 Million | 1.36 Million | 5.44 Million | -4.08 Million |
Free Cash Flow | - | - | - | - | - | - |
PHOE
ECV
DIE
600376
CRN
3234